BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38281619)

  • 1. One-year radiographic and clinical performance of bioactive materials in primary molar pulpotomy: A randomized controlled trial.
    Abdelwahab DH; Kabil NS; Badran AS; Darwish D; Abd El Geleel OM
    J Dent; 2024 Apr; 143():104864. PubMed ID: 38281619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report.
    Eidelman E; Holan G; Fuks AB
    Pediatr Dent; 2001; 23(1):15-8. PubMed ID: 11242724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
    Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
    Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.
    Noorollahian H
    Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth.
    Agamy HA; Bakry NS; Mounir MM; Avery DR
    Pediatr Dent; 2004; 26(4):302-9. PubMed ID: 15344622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.
    Alqaderi HE; Al-Mutawa SA; Qudeimat MA
    J Dent; 2014 Nov; 42(11):1390-5. PubMed ID: 24973732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study.
    Olatosi OO; Sote EO; Orenuga OO
    Niger J Clin Pract; 2015; 18(2):292-6. PubMed ID: 25666010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study.
    Subramaniam P; Konde S; Mathew S; Sugnani S
    J Clin Pediatr Dent; 2009; 33(4):311-4. PubMed ID: 19725237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and radiographic comparison of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in primary molars.
    Patidar S; Kalra N; Khatri A; Tyagi R
    J Indian Soc Pedod Prev Dent; 2017; 35(4):367-373. PubMed ID: 28914251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up.
    Frenkel G; Kaufman A; Ashkenazi M
    J Clin Pediatr Dent; 2012; 37(2):137-41. PubMed ID: 23534318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium hydroxide vs mineral trioxide aggregates for partial pulpotomy of permanent molars with deep caries.
    Qudeimat MA; Barrieshi-Nusair KM; Owais AI
    Eur Arch Paediatr Dent; 2007 Jun; 8(2):99-104. PubMed ID: 17555692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Glenny AM; Courson F; Durieux P; Muller-Bolla M; Fron Chabouis H
    Cochrane Database Syst Rev; 2018 May; 5(5):CD003220. PubMed ID: 29852056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars.
    Liu H; Zhou Q; Qin M
    Chin J Dent Res; 2011; 14(2):121-5. PubMed ID: 22319753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of formocresol and mineral trioxide aggregate in pulpotomized primary molars--2 year follow up.
    Airen P; Shigli A; Airen B
    J Clin Pediatr Dent; 2012; 37(2):143-7. PubMed ID: 23534319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial.
    Sakai VT; Moretti AB; Oliveira TM; Fornetti AP; Santos CF; Machado MA; Abdo RC
    Br Dent J; 2009 Aug; 207(3):E5; discussion 128-9. PubMed ID: 19629145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term evaluation of primary teeth molar pulpotomies with Biodentine and MTA: a CONSORT randomized clinical trial.
    Vilella-Pastor S; Sáez S; Veloso A; Guinot-Jimeno F; Mercadé M
    Eur Arch Paediatr Dent; 2021 Aug; 22(4):685-692. PubMed ID: 33683572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy.
    Doyle TL; Casas MJ; Kenny DJ; Judd PL
    Pediatr Dent; 2010; 32(1):41-7. PubMed ID: 20298652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D; Jayanthi M
    Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of full pulpotomy in mature permanent molars using 3 calcium silicate-based materials: A parallel, double blind, randomized controlled trial.
    Taha NA; Al-Rawash MH; Imran ZA
    Int Endod J; 2022 May; 55(5):416-429. PubMed ID: 35152464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth.
    Çelik BN; Mutluay MS; Arıkan V; Sarı Ş
    Clin Oral Investig; 2019 Feb; 23(2):661-666. PubMed ID: 29744721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.